Executives - Verlapharm v. Ehrlich AG Buy the executives list from same sector
Herr Andreas Georg Weidmann
CEO - Chief Executive Officer (Geschäftsleitung, Geschäftsführer)
Location - Verlapharm v. Ehrlich AG
Activities - Verlapharm v. Ehrlich AG
Main activities within the Kompass classification
Secondary activities within the Kompass classification
- Pharmaceutical preparations for the central and autonomic nervous system and anaesthetics
- Pharmaceutical preparations for the cardiovascular system
- Pharmaceutical preparations for ear, nose and throat (ENT) and dentistry
- Pharmaceutical preparations for ophthalmology
- Pharmaceutical preparations for metabolism, nutrition, alimentary systems
- Pharmaceutical preparations for dermatology
- Pharmaceutical preparations for urology, gynaecology and obstetrics
- Wholesale trade
Kompass membership
| Kompass ID? | CH088708 |
|---|
Legal information - Verlapharm v. Ehrlich AG
| Type | Headquarters |
|---|---|
| Year established | 1974 |
| Legal form | Limited company |
| Activity | |
| Corporate capital | 50,000 CHF |
| Registration No. | CHE-103.612.430 |
| VAT no |
CHE-103.612.430 MwSt |
General Information - Verlapharm v. Ehrlich AG
| Export area |
|
|---|
Other Companies recommended by Kompass:
You might also like:
Need help finding the right information ? Let us guide you to the best solutions !
I am looking for :
The shortest path to your future customers and suppliers
"I would recommend EasyBusiness to all sales teams."
Test EasyBusiness for 14 days for free
No payment or credit card required
All-in-one prospecting solution designed to improve your productivity
Find your next customer today! Your shortcut to faster, more targeted and successful lead generation
Register for free and turn reliable data into real business opportunities
Your data is used to recontact you or send you communications and may be processed by Kompass, for the purposes of legitimate interest (Article 6 1.f of the GDPR).
You may object to its processing by email: dpo@kompass.com.
Find out more: see our privacy policy.